Trends in HIV-and STD-Related Risk Behaviors Among High School Students -United States, 1991-2007
Persons who engage in unprotected sexual intercourse or use injection drugs are at increased risk for human immuno deficiency virus (HIV) infection and sexually transmitted dis eases (STDs). Changes in HIV-and STD-related risk behaviors among high school students in the United States during 1991-2005 were reported previously (1) . To update these analyses through 2007, CDC analyzed data from nine biennial national Youth Risk Behavior Surveys (YRBS). This report summarizes the results of that analysis, which indicated that, during 1991-2007, the percentage of U.S. high school stu dents who ever had sexual intercourse decreased 12%, the percentage who had sexual intercourse with four or more per sons during their lifetime decreased 20%, and the percentage who were currently sexually active decreased 7%. Among stu dents who were currently sexually active, the prevalence of condom use increased 33%. However, these changes in risk behaviors were not observed in some subgroups. In addition, no changes were detected in the prevalence of sexual risk behaviors from 2005 to 2007, and many students still engaged in behaviors that place them at risk for HIV infection and STDs. Additional efforts to reduce sexual risk behaviors, par ticularly among black, Hispanic, and male students, must be implemented to meet the Healthy People 2010 national health objective for adolescent sexual behaviors (objective no. 25 11) (2) and to decrease rates of HIV infection and STDs.
The biennial national YRBS, a component of CDC's Youth Risk Behavior Surveillance System, used independent, threestage cluster samples for the 1991-2007 surveys to obtain cross-sectional data representative of public and private school students in grades 9-12 in all 50 states and the District of Columbia (3) . Sample sizes ranged from 10,904 to 16,296. School response rates ranged from 70% to 81%, and student response rates ranged from 83% to 90%; therefore, overall response rates for the surveys ranged from 60% to 70%.
For each cross-sectional national survey, students completed anonymous, self-administered questionnaires that included identically worded questions about sexual intercourse, num ber of sex partners, condom use, and injection-drug use.* Sexual experience was defined as ever having had sexual inter course. Multiple sex partners was defined as having four or more sex partners during one's lifetime. Current sexual activ ity was defined as having sexual intercourse during the 3 months before the survey. Condom use was defined as use of a condom during last sexual intercourse among currently sexually active students. Injection-drug use was defined as ever having used a needle to inject any illegal drug into one's body. Race/ethnicity data are presented only for non-Hispanic black, non-Hispanic white, and Hispanic students (who might be of any race); the numbers of students from other racial/ethnic groups were too small for meaningful analysis.
Data were weighted to provide national estimates (3) , and the statistical software used for all data analyses accounted for the complex sample design. Temporal changes were analyzed using logistic regression analyses, which controlled for sex, race/ethnicity, and grade and simultaneously assessed signifi cant (p<0.05) linear and quadratic time effects. † T-test analy ses were used to test for significant (p<0.05) differences between results from 2005 and 2007.
During 1991-2007, the prevalence of sexual experience decreased 12% overall, from 54.1% to 47.8%. Logistic regression analyses indicated a significant linear decrease overall and among female, male, 9th-grade, 10th-grade, 11th-grade, 12th-grade, black, and white students (Table) . Among His panic students, no significant change was detected. Among male students, 11th-grade students, and black students, a sig nificant quadratic trend also was detected. Among male stu dents and 11th-grade students, the prevalence of sexual experience declined during 1991-1997 and then leveled off during 1997-2007. Among black students, the prevalence of sexual experience declined during 1991-2001 and then lev eled off during [2001] [2002] [2003] [2004] [2005] [2006] [2007] . From 2005 to 2007, no signifi cant change was detected in the prevalence of sexual experience overall or among any sex, grade, or racial/ethnic subgroup of students.
During 1991-2007, the prevalence of multiple sex partners decreased 20%, from 18.7% to 14.9%. A significant linear decrease was detected overall and among female, male, 9th-grade, 10th-grade, 11th-grade, 12th-grade, black, and white students (Table) . Among Hispanic students, no signifi cant change was detected. A significant quadratic trend also was detected among male students, 11th-grade students, and 12th-grade students. For each group, the prevalence of mul tiple sex partners declined during 1991-1997 and then lev eled off during [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] . From 2005 to 2007, no significant change was detected in the prevalence of multiple sex part ners overall or among any sex, grade, or racial/ethnic subgroup of students.
During 1991-2007, the prevalence of current sexual activ ity decreased 7%, from 37.5% to 35.0%. A significant linear decrease was detected overall and among 9th-grade students and black students (Table) . Among 9th-grade and 11th-grade students, a significant quadratic trend was detected. For 9th-grade students, the prevalence of current sexual activity remained stable during 1991-1999 and then declined during 1999-2007. For 11th-grade students, the prevalence of cur rent sexual activity declined during 1991-1999 and then † A quadratic trend indicates a significant but nonlinear trend in the data over time; whereas a linear trend is depicted with a straight line, a quadratic trend is depicted with a curve with one bend. Trends that include significant quadratic and linear components demonstrate nonlinear variation in addition to an overall increase or decrease over time.
Editorial Note: A Healthy People 2010 national health objec tive (no. 25-11) is to increase to 95% the proportion of ado lescents in grades 9-12 who abstain from sexual intercourse or use condoms if currently sexually active (2) . CDC reported previously that, in 2007, 87% of high school students reported abstaining from sexual intercourse or using condoms if cur rently sexually active (4), compared with 80% in 1991. Despite this progress, the analyses in this report indicate that no changes were detected in the prevalence of sexual risk behaviors from 2005 to 2007, and some subgroups did not experience the overall changes observed during 1991-2007. For example, among black students, the prevalence of sexual experience, multiple sex partners, and current sexual activity remained higher than among any other subgroup of high school students, the prevalence of sexual experience did not decrease during [2001] [2002] [2003] [2004] [2005] [2006] [2007] , and the prevalence of condom use did not increase during 1999-2007. Among Hispanic students, the prevalence of sexual experience, multiple sex part ners, and current sexual activity did not change during 1991-2007. Among male students, the prevalence of sexual experience and multiple sex partners did not decrease after 1997, and current sexual activity did not change during [1991] [1992] [1993] [1994] [1995] [1996] [1997] [1998] [1999] [2000] [2001] [2002] [2003] [2004] [2005] [2006] [2007] . Therefore, renewed efforts to delay onset of sexual ac tivity and increase condom use among students who are sexually active are warranted, especially among black, His panic, and male students. The findings in this report are subject to at least two limita tions. First, these data apply only to youths who attend school and therefore are not representative of all persons in this age group. In 2005, of persons aged 16-17 years in the United States, approximately 3% were not enrolled in a high school program and had not completed high school (5) . Second, the extent of underreporting or overreporting of behaviors can not be determined, although the survey questions demon strated good test-retest reliability (6) .
The lack of recent change in the prevalence of HIV-and STD-related risk behaviors among high school students might have contributed to recent increases in related health outcomes. (9) . Programs and activities aimed at addressing these health outcomes should involve parents and families, schools, youth-serving organiza tions, health-care providers, the media, government agencies, and youths themselves. ¶ Had sexual intercourse during the 3 months before the survey. ** Used a condom during last sexual intercourse (among students who were currently sexually active). † † Ever used a needle to inject any illegal drug into their body. The wording of the question on injection-drug use changed substantially after the 1993 survey, so 1991 and 1993 data are not included. § § Significant linear effect (p<0.05). ¶ ¶ Significant quadratic effect (p<0.05). *** Numbers of students in racial/ethnic groups other than non-Hispanic black, Hispanic, or non-Hispanic white were too small for meaningful analysis.
Hispanic students might be of any race.
HIV Prevention Education and HIV-Related Policies in Secondary Schools -Selected Sites, United States, 2006
Persons who engage in sexual risk behaviors are at increased risk for human immunodeficiency virus (HIV) infection. School health education can help reduce the prevalence of sexual risk behaviors among students (1) . In addition, school health policies can help protect the rights and health of HIVinfected students and staff members and reduce the likelihood of transmitting HIV infection to others (2) . To determine the prevalence and extent of HIV prevention education and the prevalence of HIV infection policies among public secondary schools,* CDC analyzed data from the 2006 School Health Profiles for schools in 36 states and 13 large urban school districts. The results of that analysis indicated that, in 2006, the majority of secondary schools included HIV prevention in a required health education course (state median: 84.2%; district median: 57.2%); however, few secondary schools (state median: 21.1%; district median: 28.5%) taught all 11 topics listed in the questionnaire related to HIV prevention. Approxi mately half of schools (state median: 51.6%; district median: 48.3%) had a policy regarding students or staff members with HIV infection or acquired immunodeficiency syndrome (AIDS). To help reduce HIV-related risk behavior and pro tect the rights and health of HIV-infected students and staff members, schools should increase efforts to teach all HIV pre vention topics and implement policies regarding students or staff members with HIV infection. * Middle, junior high, and senior high schools with one or more of grades 6-12. School Health Profiles surveys have been conducted bien nially since 1994 to assess school health programs (3). States and large school districts participate in the surveys, selecting either all public secondary schools within their jurisdictions or systematic, equal-probability, representative samples of schools. † At each school, the principal and lead health educa tion teacher are sent questionnaires to be self-administered and returned to the state or local agency conducting the sur vey. Participation in School Health Profiles is confidential and voluntary. In 2006, lead health education teachers were asked questions regarding the content of required health education courses and staff development on health education topics. Principals were asked questions regarding policies on students or staff members with HIV infection or AIDS. Follow-up tele phone calls and written reminders were used to encourage participation. Data from each questionnaire were cleaned and edited by CDC. Those surveys that used a representative sample of schools, had appropriate documentation, and achieved a response rate of 70% or higher were weighted to reflect the likelihood of schools being selected and to adjust for differing patterns of nonresponse.
For the 2006 School Health Profiles survey, lead health edu cation teachers were asked the following questions: 1) "Dur ing this school year, have teachers in this school tried to increase student knowledge on each of the following topics in a required health education course in any of grades 6 through 12?" Respondents were asked to indicate yes or no on a list of topics that included "HIV prevention." 2) "During this school year, did teachers in this school teach each of the following pregnancy, HIV, or sexually transmitted disease (STD) pre vention topics in a required health education course for stu dents in any of grades 6 through 12?" The following 11 topics were listed: abstinence as the most effective method to avoid pregnancy, HIV, and STDs; how to correctly use a condom; condom efficacy; risks associated with having multiple sexual partners; social or cultural influences on sexual behavior; how to prevent HIV infection; how HIV is transmitted; how HIV affects the human body; influence of alcohol and other drugs on HIV-related risk behaviors; how to find valid information or services related to HIV or HIV testing; and compassion for persons living with HIV or AIDS. 3) "During the past 2 years, did you receive staff development (such as workshops, con ferences, continuing education, or any other kind of in-service) on each of the following health education topics?" Respon dents were asked to indicate yes or no on a list of topics that † In the 2006 survey, statewide samples were representative of all public secondary schools in the state with two exceptions: no schools from the New York City Department of Education were included in the New York state sample, and no schools from the Chicago Public Schools were included in the Illinois sample.
included "HIV prevention." Principals were asked the follow ing question: "Has this school adopted a policy on students and/or staff who have HIV infection or AIDS?" In 2006, 34 states and 13 large urban school districts § met the criteria for both their principal and lead health education teacher surveys to be weighted and two states ¶ met the crite ria for the principal survey only. Among states, the number of lead health education teachers who participated ranged from 68 to 659 (median: 250), and response rates ranged from 70% to 91% (median: 77%); among school districts, the number of lead health education teachers ranged from 32 to 212 (median: 56), and response rates ranged from 70% to 100% (median: 79%). Among states, the number of principals who participated ranged from 68 to 661 (median: 262), and response rates ranged from 70% to 91% (median: 78%); among school districts, the number of principals ranged from 31 to 234 (median: 55), and response rates ranged from 71% to 98% (median: 79%). Only 21 states and eight large urban school districts that obtained weighted data in both 1996 and 2006 were included in comparisons of data for those 2 years. The Wilcoxon rank-sum test, a nonparametric analogue to a two-sample t-test, was used to test for differences across states and school districts. Differences were considered statistically significant at p<0.05.
The percentage of secondary schools that taught HIV pre vention in a required health education course ranged from 35.6% to 99.3% (median: 84.2%) among states, and from 0.0% to 100.0% (median: 57.2%) among school districts ( Table 1 ). The percentage of schools that taught all 11 HIV prevention topics ranged from 1.0% to 53.1% (median: 21.1%) among states and from 0.0% to 66.5% (median: 28.5%) among school districts. The percentage of secondary schools that taught how to correctly use a condom ranged from 1.0% to 59.1% (median: 24.3%) among states and from 0.0% to 74.8% (median: 33.7%) among school districts. The percentage that taught about condom efficacy ranged from 11.7% to 90.0% (median: 56.0%) among states and from 0.0% to 91.1% (median: 56.0%) among school districts. For the other nine HIV prevention topics the median percentage of secondary schools that taught each in a required health § States: Alabama, Alaska, Arizona, Arkansas, Connecticut, Delaware, Florida, Editorial Note: The findings in this report indicate that, in 2006, the majority of secondary schools in 34 states and 13 school districts provided some education on HIV prevention topics in required health education courses. However, more than half the states that conducted surveys reported that less than one fourth of their schools taught all 11 HIV prevention topics listed in the questionnaire; more than half the school districts that conducted surveys reported that less than one third of their schools taught all 11 topics. Health education can increase knowledge and skills regarding how to avoid HIV infection (4) . This analysis also indicated that a median of less than 50% of lead health education teachers among states and a median of approximately two thirds among school districts had re ceived staff development on HIV prevention. Staff develop ment on health topics is critical for effective teaching (5) .
The finding that in approximately half of the states and school districts conducting surveys, less than 50% of second ary schools had a policy on students or staff members with HIV infection or AIDS is consistent with previously reported national data (6) . In addition, the median percentage of schools with such a policy has decreased since 1996. Reasons for these decreases warrant further investigation. Policies for address ing HIV infection in the school setting can provide guidance, support, and protection to those who are infected and to other students and staff members, families, and community mem bers. These groups, along with public health and legal profes sionals, should work together to develop and implement HIV-related policies and continually assess them, based on new legislation, scientific data, and real-world experience (2) .
The findings in this report are subject to at least three limi tations. First, these data apply only to public secondary schools and, therefore, do not reflect practices at private schools or elementary schools. Second, these data were self-reported by principals and lead health education teachers and were not verified by other sources. Finally, these data were collected during spring and fall 2006 and do not reflect any state, dis trict, or school policies enacted, modified, or discontinued since then.
Despite limitations, School Health Profiles remains an important tool for states and school districts to monitor the current status of HIV prevention education and HIV-related policies. These data can be used by public health and educa tion agencies to assist schools in improving their HIV preven tion curricula and HIV-related policies.
Newborn Hepatitis B Vaccination Coverage Among Children Born January 2003-June 2005 -United States
Hepatitis B vaccine was first recommended for administra tion to all infants in 1991 by the Advisory Committee on Immunization Practices (ACIP) as the primary focus of a strategy to eliminate hepatitis B virus (HBV) transmission in the United States (1). The recommended timing of adminis tration of the first dose of hepatitis B vaccine to infants has evolved since then to optimize prevention of perinatal and early childhood HBV infections. In 1991, the first dose was recommended to be administered at birth before hospital dis charge or at age 1-2 months. In 2002, ACIP indicated a pref erence for the first dose to be administered to newborns before hospital discharge (2) . In December 2005, ACIP issued revised recommendations specifying that all medically stable newborns who weigh >2,000 g (4.4 lbs) receive their first dose of hepatitis B vaccine before hospital discharge (3). To mea sure hepatitis B vaccination coverage during the neonatal pe riod, CDC analyzed data from the 2006 National Immunization Survey (NIS). This report summarizes the re sults of this analysis and provides national, state, and local data on vaccination coverage for infants who received the hepa titis B vaccine during the first days of life. The findings reveal that, during January 2003-June 2005, before implementa tion of the 2005 ACIP hepatitis B vaccine recommendation, the national newborn hepatitis B vaccination coverage esti mate was 42.8% at age 1 day and 50.1% at age 3 days, with substantial variation by states and local areas. To comply with ACIP recommendations and increase coverage, delivery hos pitals should provide hepatitis B vaccination of newborns as a standard of care.
NIS provides estimates of vaccination coverage among noninstitutionalized children aged 19-35 months for each of the 50 states and selected local areas. To collect vaccination data, NIS conducts a random-digit-dialed telephone survey of households and a mail survey of children's vaccination pro viders identified by household respondents. Data are weighted to adjust for households with multiple telephone lines, house hold nonresponse, and exclusion of households without landline telephones (4 Household response rate for the survey was 64.5%, based on Council of American Survey and Research Organizations guidelines (CASRO); 21,044 children with provider-verified vaccination records were included in this report and represent 70.4% of all children with completed household interviews. National newborn hepatitis B vaccination coverage was 42.8% at age 1 day, 48.5% at 2 days, 50.1% at 3 days, 51.1% at 4 days, 51.8% at 5 days, and 52.5% at 6 days. State and local area rates showed substantial variability, with hepatitis B vac cination coverage at age 1 day ranging from 8.2% in Fresno County, California, to 77.5% in Detroit, Michigan (Table) . Among all states and local areas surveyed, the median cover age estimate was 50.3% at age 1 day and 58.7% at 3 days. Newborn hepatitis B vaccination coverage estimates varied substantially among and within states. Administration of hepa titis B vaccine to newborns is dependent on hospital policies and procedures and on provider and parent preferences (5, 6) .
Although NIS does not distinguish whether hepatitis B vac cine was given before or after hospital discharge, National Hospital Discharge Survey data (7) indicate that the average length of hospital stay for all newborns in 2004 was 3.3 days, with an average stay of 2.1 days for well newborns and an average stay of 5.0 days for ill newborns; 85.6% of all new borns were discharged by age 3 days.
The findings in this report are subject to at least four limi tations. First, NIS is a telephone survey; although results are statistically adjusted to account for nonresponse and house holds without telephones, some bias might remain. Second, vaccination coverage is confirmed using providerverified records. Although clinic providers might not always have records of a hospital-administered hepatitis B vaccine dose, this does not appear to result in substantial underascertainment of vaccination. A 2004 study in eight locations matched provider-reported vaccination records for the chil dren sampled in NIS to their vaccination histories reported by the state Immunization Information Systems (IIS). NIS data underestimated birth dose coverage by no more than 5% at any one location when compared with the combined NIS and IIS coverage among children who had vaccination histo ries from both sources (M Khare, CDC, personal communi cation, February 2008). Third, estimates from state and local areas should be interpreted with caution because of smaller sample size and wider confidence intervals compared with the national estimate. Finally, infants who were not recommended to receive hepatitis B vaccine until age 1 month or after hos pital discharge because their birth weights were <2,000 g and they were born to HBsAg-negative mothers could not be excluded from the coverage estimates. Inclusion of those infants in the denominator might result in an underestimate of newborn coverage, but the effect should be minimal because infants at this birth weight account for only 3% of births (8) .
Infants infected with HBV typically are asymptomatic and have a 90% likelihood of remaining chronically infected (3). Up to 25% of chronically infected children die prematurely of cirrhosis or liver cancer (9) . Two primary modes of HBV transmission occur during infancy and early childhood: 1) from an infected mother to her infant during delivery, and 2) from infected household contacts to infant or child. Both modes of transmission can be prevented by immunization of newborn infants. For infants born to mothers identified as hepatitis B surface antigen (HBsAg)-positive (i.e., HBVinfected), administration of hepatitis B vaccine and hepatitis B immune globulin within 12 hours of birth is 85%-95% effective as postexposure prophylaxis in preventing HBV in fection in the infant. In addition, hepatitis B vaccine alone is 70%-95% effective in preventing perinatal HBV transmis sion when the first dose is given within 24 hours of birth. Thus, administration of hepatitis B vaccine soon after birth provides timely postexposure prophylaxis to infants born to HBsAg-positive mothers who were not screened prenatally, or were not identified as HBsAg-positive because of testing errors or lapses in reporting or documentation of test results (10). Hepatitis B vaccination of all newborns also provides early preexposure protection to infants born to uninfected women during a period when the risk for developing chronic HBV infection is greatest.
The 2005 ACIP recommendation to administer the first dose of hepatitis B vaccine to all newborns before hospital discharge will increase hepatitis B vaccination coverage dur ing the first days of life. Delivery hospitals play a key role in the national strategy to eliminate HBV transmission. The 2005 ACIP statement recommends that delivery hospitals have poli cies and procedures in place, including appropriate standing orders, to ensure 1) administration of hepatitis B vaccine to all newborns with birth weights >2,000 g before hospital dis charge and 2) identification of all infants born to HBsAg positive mothers and infants born to mothers with unknown HBsAg status to allow initiation of postexposure prophylaxis within 12 hours of birth. State and local information on pre vention of HBV infection in infants and children, including information on hospital-based policies and procedures to pre vent HBV infection, is available through CDC-funded peri natal hepatitis B prevention coordinators based in state health departments. Contact information for those coordinators is available at http://www.cdc.gov/vaccines/vpd-vac/hepb/peri natal-contacts.htm. EIS is a 2-year, postgraduate program of service and on-the-job training for health professionals interested in the practice of epidemiology. Each year, EIS provides approxi mately 90 persons, selected from applicants around the world, opportunities to gain hands-on experience in epidemiology at CDC or at state or local health departments. EIS officers, often called CDC's "disease detectives," have gone on to occupy leadership positions at CDC and other public health agencies nationally and internationally. However, the experi ence also is useful for health professionals who want to gain a population health perspective.
Persons with a strong interest in applied epidemiology who meet at least one of the following qualifications may apply to EIS:
• physicians with >1 year of clinical training;
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- 0 0 - - - 0 1 3 3 - 0 0 - - C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 0 - 2 -- - 0 0 - 14 N 0 0 N N C.N.M.I. - - - - - - - - - - - - - - - G u a m - 0 0 - - - 0 1 - 2 - 0 0 - - Puerto Rico -5 - 0 2 - - - 0 2 2 4 Montana § - 0 2 2 1 - 0 0 - 3 - 0 1 4 1 Nevada § 1 0 2 3 6 - 0 3 4 2 - 0 2 6 3 New Mexico § - 0 2 3 4 - 0 1 1 2 - 0 1 5 2 U t a h - 0 1 - 2 - 0 1 2 9 - 0 2 3 8 Wyoming § - 0 1 1 2 - 0 0 - - - 0 1 2 2
Pacific
N 0 0 N N - 0 0 - - - 0 0 - - C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 0 - - - 0 1 1 1 - 0 0 - - Puerto Rico N 0 0 N N - 0 1 1 2 - 0 1 2 6 U.S. Virgin Islands N 0 0 N N - 0 0 - - - 0 0 - - C.N.- 0 0 - - N 0 0 N N American Samoa - 0 0 - - N 0 0 N N N 0 0 N N C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 0 - - - 0 0 - - N 0 0 N N Puerto Rico - 0 0 - - - 10 1 1 - - 0 0 - - - 0 1 1 3 C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 2 8 11 - 0 0 - - -
